These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6804088)

  • 41. [Mitomycin C: current status of knowledge and use in laryngeal tumors].
    Giorgi G; Bertelli E; Salvini M; Aragona P
    Arch Sci Med (Torino); 1983; 140(1):45-50. PubMed ID: 6409052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of chemotherapy with mitomycin C and 5-FU on pancreatic functions in patients with gastric cancer.
    Fujii M
    Cancer Treat Rep; 1980; 64(10-11):1151-2. PubMed ID: 7006806
    [No Abstract]   [Full Text] [Related]  

  • 43. [Four long-surviving cases of gastric cancer with peritoneal dissemination treated by intraperitoneal administration of mitomycin C adsorbed on activated carbon particles].
    Sakakibara T; Oyama T; Ozaki K; Sasaki S; Tsujimoto H; Sakakura C; Shimotsuma M; Hagiwara A; Takahashi T
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1700-2. PubMed ID: 8373253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pre-operative chemotherapy of stomach cancer combined with local administration of OK-432--evaluation of macroscopic results].
    Mukai M; Den N; Yamazaki Y; Namiki S; Oda S; Nagao K
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):96-102. PubMed ID: 6820880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Undifferentiated leukemia following treatment of gastric cancer with 5 fluorouracil, doxorubicin, mitomycin C chemotherapy.
    Gupta S; Raina V; Jain P; Gujral S; Kumar R
    J Assoc Physicians India; 2000 Jun; 48(6):639-40. PubMed ID: 11273547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Doxorubicin, mitomycin, and 5-FU (DMF) in the treatment of hormone-resistant stage D prostate cancer: a preliminary report.
    Logothetis CJ; von Eschenbach AC; Samuels ML; Trindade A; Johnson DE
    Cancer Treat Rep; 1982 Jan; 66(1):57-63. PubMed ID: 7053267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma.
    Hartmann JT; Kanz L; Bokemeyer C
    Anticancer Res; 2000; 20(2B):1177-82. PubMed ID: 10810418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical evaluation of various antineoplastic agents combined with urokinase--a comparison between urokinase from tissue culture (TCUK) and urine-derived urokinase (UUK)].
    Yamamoto M
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1461-73. PubMed ID: 6820918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A clinical nude mouse metastatic model for highly malignant human pancreatic cancer.
    An Z; Wang X; Kubota T; Moossa AR; Hoffman RM
    Anticancer Res; 1996; 16(2):627-31. PubMed ID: 8687107
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Current aspects of diagnosis and therapy of pancreatic carcinoma].
    Rosewicz S
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():62-3. PubMed ID: 12467013
    [No Abstract]   [Full Text] [Related]  

  • 51. Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700.
    Isacoff WH; Bendetti JK; Barstis JJ; Jazieh AR; Macdonald JS; Philip PA
    J Clin Oncol; 2007 May; 25(13):1665-9. PubMed ID: 17470859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Factors affecting the effect of anticancer drugs. 1. The effect of mitomycin C in vitro and in vivo].
    Ishikawa Y; Fukushima M; Horimai T; Sato T; Machida S
    Igaku To Seibutsugaku; 1967 Feb; 74(2):96-100. PubMed ID: 5624336
    [No Abstract]   [Full Text] [Related]  

  • 53. Gastric cancer: a controlled trial of adjuvant chemotherapy following gastrectomy.
    Blake JR; Hardcastle JD; Wilson RG
    Clin Oncol; 1981 Mar; 7(1):13-21. PubMed ID: 7011643
    [No Abstract]   [Full Text] [Related]  

  • 54. [Multihospital randomized study on the adjuvant chemotherapy with mitomycin-C and Futraful for gastric cancer V. Estimation of 5-year survival rate].
    Kondo T; Inokuchi K; Hattori T; Inoue K; Taguchi T; Akiyama H; Abe O; Ito I; Nakajima T; Muto T; Kikuchi K; Kasai Y; Sugie S; Hayasaka A
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):2016-24. PubMed ID: 6820887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Guideline for proper use of antineoplastic agents. Cancer of the digestive system--malignant cancers (stomach, colonic, and pancreatic cancers)].
    Sasaki T; Maeda Y; Mukoyama O
    Gan To Kagaku Ryoho; 2002 Jun; 29(6):1008-14. PubMed ID: 12109442
    [No Abstract]   [Full Text] [Related]  

  • 56. Adjuvant therapy for resectable gastric adenocarcinoma: preoperative and postoperative chemotherapy trials.
    Leach SD; Lowy AM; Mansfield PF; Ajani JA
    J Infus Chemother; 1995; 5(3):104-11. PubMed ID: 8528966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Alternatives to surgical treatment of adenocarcinomas of the esophagus and the cardia].
    Seitz JF
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D67-70. PubMed ID: 8013789
    [No Abstract]   [Full Text] [Related]  

  • 58. [Update on gastroenterology].
    Ychou M; Senesse P; Quenet F
    Bull Cancer; 1998 Jan; 85(1):37-41. PubMed ID: 9752344
    [No Abstract]   [Full Text] [Related]  

  • 59. [2 cases of aplastic anemia and renal disorders due to mitomycin C].
    Tomura T; Takizawa Y; Irikae K; Korenaga O; Higo O
    Gan No Rinsho; 1966 Mar; 12(3):173-6. PubMed ID: 6010939
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical evaluation of the combined therapy of surgery and anticarcinogenic agents].
    Nakazato H
    Shujutsu; 1967 Sep; 21(9):934-44. PubMed ID: 5592183
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.